We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will GNC Holdings (GNC) Disappoint This Earnings Season?
Read MoreHide Full Article
GNC Holdings, Inc. (GNC - Free Report) , a specialty retailer of health and nutrition related products, is scheduled to report third-quarter 2017 results on Oct 26, before the opening bell.
Last quarter, the company posted a positive earnings surprise of 2.5%. However, GNC Holdings’ trailing four-quarter earnings average miss stands at 19.9%.
Let’s see how things are shaping up prior to this announcement.
Factors at Play
GNC Holdings' last reported second-quarter 2017 revenues dropped 4.8% year over year. Apart from lower sales at the U.S. & Canada international and manufacturing/wholesale segments, the decline in revenues can be attributed to an overall drop in sales of protein, vitamins, weight management and food and drink categories. In absence of any catalyst to drive growth, we expect a similar trend in the third quarter of 2017 as well.
Moreover, GNC Holdings has a number of competitors in the market that include large international pharmacy chains, supermarket firms and big U.S.-based companies with global operations. Thus, we expect the company to slash product prices in the face of stiff competition, which in turn, might hurt margins.
Also, currency headwinds continue to be a growing concern for GNC Holdings. Management also expects the failure to comply with FTC regulations and changing consumer preferences to hamper business.
However, on the bright side, the performance of One New GNC is improving gradually. Also, in the last reported quarter, PRO Access members doubled their visits, purchased double the products and spent significantly more in the second quarter. Banking on these factors, we expect the company to continue to gain in the yet-to-be-reported quarter as well. Meanwhile, new consumer enrolment under the myGNC Rewards Program and launch of GNC storefront on Amazon buoy optimism.
Earnings Whispers
Our proven model does not conclusively show an earnings beat for GNC Holdings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here, as you will see below.
Zacks ESP: The Earnings ESP for GNC Holdings is -14.50%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: GNC Holdings carries a Zacks Rank #3, which increases the predictive power of ESP. However, we also need to have a positive ESP to be confident of a positive earnings surprise.
Stocks to Consider
Here are a few medical stocks worth considering as they have the right combination of elements to post an earnings beat this quarter.
Henry Schein, Inc. (HSIC - Free Report) has an Earnings ESP of +0.62% and a Zacks Rank #3.
Thermo Fisher Scientific Inc. (TMO - Free Report) has an Earnings ESP of +0.33% and a Zacks Rank #2.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Image: Bigstock
Will GNC Holdings (GNC) Disappoint This Earnings Season?
GNC Holdings, Inc. (GNC - Free Report) , a specialty retailer of health and nutrition related products, is scheduled to report third-quarter 2017 results on Oct 26, before the opening bell.
Last quarter, the company posted a positive earnings surprise of 2.5%. However, GNC Holdings’ trailing four-quarter earnings average miss stands at 19.9%.
Let’s see how things are shaping up prior to this announcement.
Factors at Play
GNC Holdings' last reported second-quarter 2017 revenues dropped 4.8% year over year. Apart from lower sales at the U.S. & Canada international and manufacturing/wholesale segments, the decline in revenues can be attributed to an overall drop in sales of protein, vitamins, weight management and food and drink categories. In absence of any catalyst to drive growth, we expect a similar trend in the third quarter of 2017 as well.
Moreover, GNC Holdings has a number of competitors in the market that include large international pharmacy chains, supermarket firms and big U.S.-based companies with global operations. Thus, we expect the company to slash product prices in the face of stiff competition, which in turn, might hurt margins.
GNC Holdings, Inc. Price and EPS Surprise
GNC Holdings, Inc. Price and EPS Surprise | GNC Holdings, Inc. Quote
Also, currency headwinds continue to be a growing concern for GNC Holdings. Management also expects the failure to comply with FTC regulations and changing consumer preferences to hamper business.
However, on the bright side, the performance of One New GNC is improving gradually. Also, in the last reported quarter, PRO Access members doubled their visits, purchased double the products and spent significantly more in the second quarter. Banking on these factors, we expect the company to continue to gain in the yet-to-be-reported quarter as well. Meanwhile, new consumer enrolment under the myGNC Rewards Program and launch of GNC storefront on Amazon buoy optimism.
Earnings Whispers
Our proven model does not conclusively show an earnings beat for GNC Holdings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here, as you will see below.
Zacks ESP: The Earnings ESP for GNC Holdings is -14.50%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: GNC Holdings carries a Zacks Rank #3, which increases the predictive power of ESP. However, we also need to have a positive ESP to be confident of a positive earnings surprise.
Stocks to Consider
Here are a few medical stocks worth considering as they have the right combination of elements to post an earnings beat this quarter.
The Cooper Companies, Inc. (COO - Free Report) has an Earnings ESP of +0.43% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Henry Schein, Inc. (HSIC - Free Report) has an Earnings ESP of +0.62% and a Zacks Rank #3.
Thermo Fisher Scientific Inc. (TMO - Free Report) has an Earnings ESP of +0.33% and a Zacks Rank #2.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>